Serina Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -7.79%
- Market cap
- $37.73M
- 26.57M shares
- Filings
- 521
Q3 2026+132.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−16.8% FY25 yoy
- $37.73M
- —
- 290.2×
- 2.7×
- -47.75%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $130,000 | reported | |
| FY 2024 | 2024-12-31 | $56,000 | reported | |
| FY 2023 | 2023-12-31 | $3,153,000 revised | reported | |
| FY 2022 | 2022-12-31 | $34,000 | reported | |
| FY 2021 | 2021-12-31 | $144,000 | reported | |
| FY 2020 | 2020-12-31 | $361,000 revised | reported | |
| FY 2019 | 2019-12-31 | $1,728,000 | reported | |
| FY 2018 | 2018-12-31 | $1,396,000 | reported | |
| FY 2017 | 2017-12-31 | $1,404,000 | reported |
Segments
LineFY2025ShareChange
Reportable Segment$130.00K100%+132.1%
Reportable Segment———
Total$130.00K
Pharmaceutical preparations
Serina Therapeutics, Inc. is the 240th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GDTCCytoMed Therapeutics Ltd$252.3K395.9%1,227.1%$9.8MRGBPRegen BioPharma Inc$236.6K0.0%538.8%$393.7KCLNNClene Inc.$200.0K41.5%13,086.5%$59.8MLSTALisata Therapeutics, Inc.$170.0K83.0%9,756.5%$10.8M
SERSerina Therapeutics, Inc. (this company)$130.0K132.1%14,755.4%$37.7M
BFRGBullFrog AI Holdings, Inc.$116.7K—5,569.6%$10.4MIBIOiBio, Inc.$100.0K75.0%33,044.0%$53.9MATNMActinium Pharmaceuticals, Inc.$90.0K—37,652.2%$44.8MSILOSilo Pharma, Inc.$72.1K0.0%5,863.5%$3.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR